Aker BioMarine, a biotech and krill harvesting company, has received its first patent allowance for its PL+ DHA/EPA delivery technology platform. This new patent application specifically protects the PL+ EPA/DHA technology, which combines krill phospholipids with EPA and DHA from processed fish oil.
The PL+ formulation, launched in late 2022, uses natural marine phospholipids to improve the uptake of other ingredients in a formulation. It enhances solubility in both fats and water, acts as an emulsifier, and boosts absorption to improve supplement uptake according to Aker BioMarine. The patent highlights the enhanced emulsions created by the combination of krill phospholipids and added ethyl esters or triglycerides, which are believed to be crucial for improving the absorption of EPA and DHA in the stomach.
Simon Seward, CEO of Human Health Ingredients, commented on the patent, emphasizing how it showcases Aker BioMarine’s innovative advancements in the industry. He highlighted the importance of personalization and combination products for consumers in today’s market. Seward also mentioned that the PL+ technology can help reduce fish oil formula integration, increase bioavailability, enhance consumer experience, and enable new innovations in the health category, especially during times of fish oil supply and demand challenges.
Aker BioMarine’s PL+ technology is a significant breakthrough in the supplement industry as it enhances bioavailability by improving absorption rates. This innovation will benefit consumers who struggle with digestive issues or have difficulty absorbing nutrients from supplements.
The patent application outlines specific features of the lipid formulations such as a certain percentage of total phospholipids and DHA/EPA in ethyl ester form to create emulsions with desirable droplet sizes in the stomach. This feature allows for precise control over product dosage and ensures consistent results.
Overall, this patent application marks an important milestone for Aker BioMarine as it continues to innovate within the biotech industry. With its unique approach to nutrient delivery, this company is poised to revolutionize health supplementation for years to come.
